MMA
CVS icon

Miracle Mile Advisors’s CVS Health CVS Stock Holding History

Miracle Mile Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Sell
7,177
-227
-3% -$17.5K 0.01% 571
2025
Q4 		$588K Buy
7,404
+1,046
+16% +$82.5K 0.01% 533
2025
Q3 		$479K Sell
6,358
-4,296
-40% -$294K 0.01% 557
2025
Q2 		$735K Buy
10,654
+180
+2% +$11.8K 0.01% 417
2025
Q1 		$710K Buy
10,474
+1,543
+17% +$92.3K 0.01% 378
2024
Q4 		$401K Sell
8,931
-2,471
-22% -$139K 0.01% 471
2024
Q3 		$717K Sell
11,402
-4,278
-27% -$250K 0.02% 318
2024
Q2 		$926K Sell
15,680
-3,453
-18% -$216K 0.02% 277
2024
Q1 		$1.53M Buy
19,133
+306
+2% +$23.4K 0.04% 210
2023
Q4 		$1.49M Sell
18,827
-9,878
-34% -$703K 0.04% 202
2023
Q3 		$2M Sell
28,705
-249
-0.9% -$17.6K 0.06% 174
2023
Q2 		$2M Sell
28,954
-6,794
-19% -$483K 0.06% 179
2023
Q1 		$2.66M Sell
35,748
-2,209
-6% -$185K 0.09% 160
2022
Q4 		$3.54M Buy
37,957
+15,343
+68% +$1.48M 0.12% 147
2022
Q3 		$2.16M Buy
22,614
+1,032
+5% +$102K 0.1% 137
2022
Q2 		$2M Buy
21,582
+4,983
+30% +$486K 0.09% 150
2022
Q1 		$1.68M Sell
16,599
-299
-2% -$31.4K 0.07% 175
2021
Q4 		$1.74M Sell
16,898
-783
-4% -$72.4K 0.07% 194
2021
Q3 		$1.5M Buy
17,681
+1,905
+12% +$160K 0.07% 199
2021
Q2 		$1.32M Buy
15,776
+378
+2% +$31K 0.07% 189
2021
Q1 		$1.16M Sell
15,398
-2,009
-12% -$146K 0.07% 192
2020
Q4 		$1.19M Buy
17,407
+2,630
+18% +$171K 0.07% 189
2020
Q3 		$863K Sell
14,777
-34,540
-70% -$2.15M 0.06% 192
2020
Q2 		$3.2M Buy
49,317
+40,874
+484% +$2.57M 0.26% 83
2020
Q1 		$501K Buy
+8,443
New +$564K 0.05% 180
2019
Q3 		– Sell
-28,705
Closed -$1.56M – 279
2019
Q2 		$1.56M Buy
28,705
+3,516
+14% +$189K 0.12% 136
2019
Q1 		$1.36M Buy
+25,189
New +$1.55M 0.11% 141

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Miracle Mile Advisors's CVS Position: Q1 2026 in Review

Miracle Mile Advisors reduced its CVS Health (CVS) stake by 3.1% in Q1 2026, selling an estimated $17.5K and leaving 7,177 shares worth $515K. The position accounts for 0.01% of the portfolio, ranked #571.

Miracle Mile Advisors first reported a position in CVS in Q1 2019 and has held it in 27 quarters since. The position peaked at $3.54M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Miracle Mile Advisors held 7,177 shares of CVS Health worth $515K as of Q1 2026.
  • Miracle Mile Advisors sold 227 CVS Health shares in Q1 2026, an estimated $17.5K.
  • CVS Health made up 0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #571 holding.
  • Miracle Mile Advisors first reported a position in CVS Health in Q1 2019 and has held it in 27 quarters since.
  • Miracle Mile Advisors's CVS Health position peaked at $3.54M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.